Clinical Utility of Monitoring Tacrolimus Blood Concentrations in Liver Transplant Patients
- 1 May 2001
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (5) , 542-551
- https://doi.org/10.1177/00912700122010429
Abstract
The relationship between the dose of tacrolimus, trough tacrolimus blood concentration, and selected clinical endpoints (acute rejection, nephrotoxicity, and other toxicities) were examined in a pros...Keywords
This publication has 20 references indexed in Scilit:
- Current opinions on therapeutic drug monitoring of immunosuppressive drugsClinical Therapeutics, 1999
- A Simplified Whole Blood Enzyme-linked Immunosorbent Assay (ProTrac II) for Tacrolimus (FK506) Using Proteolytic Extraction in Place of Organic SolventsTherapeutic Drug Monitoring, 1996
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive TherapyClinical Pharmacokinetics, 1996
- Therapeutic Drug Monitoring of Tacrolimus in Clinical TransplantationTherapeutic Drug Monitoring, 1995
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995
- Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissueHepatology, 1995
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- FK506 TROUGH LEVELS IN WHOLE BLOOD AND PLASMA IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1994
- Liver, Kidney, and Thoracic Organ Transplantation Under FK 506Annals of Surgery, 1990